{
    "hands_on_practices": [
        {
            "introduction": "Accurate diagnosis of preeclampsia often begins with quantifying proteinuria, a cornerstone of its definition. This exercise provides a hands-on opportunity to apply a fundamental diagnostic tool: the urine protein-to-creatinine ratio. By calculating this ratio from raw laboratory values, you will practice a key skill needed to quickly and effectively assess a patient for one of the core criteria of preeclampsia. ",
            "id": "4465834",
            "problem": "A pregnant individual at $34$ weeks and $2$ days with a history of chronic hypertension presents with sustained blood pressures in the range of 140 to 150 $\\text{mmHg}$ systolic and 90 to 95 $\\text{mmHg}$ diastolic over $4$ hours, without headache, visual disturbance, right upper quadrant pain, or dyspnea. Physical examination is otherwise unremarkable. Laboratory testing reveals a platelet count of $210{,}000$ per $\\text{mm}^3$, serum creatinine of $0.7$ $\\text{mg/dL}$, alanine aminotransferase of $22$ $\\text{U/L}$, and aspartate aminotransferase of $24$ $\\text{U/L}$. A spot urine (random clean-catch) is obtained, showing urine protein concentration of $45$ $\\text{mg/dL}$ and urine creatinine concentration of $120$ $\\text{mg/dL}$.\n\nStarting from foundational definitions used in obstetric practice, the diagnosis of preeclampsia without severe features requires new-onset hypertension after $20$ weeks of gestation plus evidence of proteinuria, where proteinuria is defined by either a $24$-hour urine protein of at least $300$ $\\text{mg}$ or a protein-to-creatinine ratio in a random urine sample of at least $0.3$. The protein-to-creatinine ratio is the dimensionless quotient obtained by dividing urine protein concentration by urine creatinine concentration measured in the same sample.\n\nUsing these base definitions, compute the protein-to-creatinine ratio from the provided urine concentrations and determine whether the computed value meets the $\\ge 0.3$ threshold for proteinuria consistent with preeclampsia without severe features. Express your final computed ratio as a unitless number and round your answer to three significant figures.",
            "solution": "The task is to compute the protein-to-creatinine ratio from a spot urine sample, then compare the result to the diagnostic threshold for proteinuria used in the evaluation of preeclampsia without severe features.\n\nFoundational definitions and facts:\n- Preeclampsia is defined by new-onset hypertension after $20$ weeks of gestation plus either proteinuria or specific end-organ dysfunction. In the absence of severe features, proteinuria can be established by either a $24$-hour urine protein of at least $300$ $\\text{mg}$ or a spot urine protein-to-creatinine ratio of at least $0.3$.\n- The protein-to-creatinine ratio in a random urine sample is the dimensionless quotient given by dividing the urine protein concentration by the urine creatinine concentration measured in the same sample. Because both concentrations are measured in the same units (for example, $\\text{mg/dL}$), the units cancel, yielding a unitless ratio that approximates grams of protein per gram of creatinine over a $24$-hour period.\n\nLet the urine protein concentration be $P$ and the urine creatinine concentration be $C$. Given $P = 45$ $\\text{mg/dL}$ and $C = 120$ $\\text{mg/dL}$, the protein-to-creatinine ratio $R$ is:\n$$\nR = \\frac{P}{C} = \\frac{45}{120}.\n$$\nCompute the fraction:\n$$\n\\frac{45}{120} = \\frac{9}{24} = \\frac{3}{8} = 0.375.\n$$\nThis ratio is unitless because the $\\text{mg/dL}$ units cancel in the quotient.\n\nRounding to three significant figures:\n- The value $0.375$ already has three significant figures, so the rounded value remains $0.375$.\n\nComparison to the threshold for proteinuria:\n- The diagnostic threshold is $R \\ge 0.3$.\n- Since $0.375 \\ge 0.3$, the threshold for proteinuria is met, satisfying the proteinuria criterion for preeclampsia without severe features when combined with the described blood pressure findings, assuming no severe features are present.\n\nThe problem requests the final computed ratio as a unitless number rounded to three significant figures, which is $0.375$.",
            "answer": "$$\\boxed{0.375}$$"
        },
        {
            "introduction": "Clinical diagnosis requires synthesizing multiple data streams into a coherent assessment, moving beyond a single calculation to a holistic evaluation. This practice challenges you to integrate blood pressure readings, laboratory findings, and the absence of warning symptoms to accurately classify a patient's condition. This exercise will sharpen your ability to differentiate between gestational hypertension and preeclampsia without severe features, a crucial step in formulating a safe management plan. ",
            "id": "4465824",
            "problem": "A pregnant patient at $28$ weeks’ gestation presents for evaluation after two clinic blood pressure measurements of $146/92\\ \\mathrm{mm\\ Hg}$ and $150/94\\ \\mathrm{mm\\ Hg}$ obtained $4$ hours apart. She reports no headache, visual changes, right upper quadrant or epigastric pain, dyspnea, or decreased fetal movement. On examination, there is no edema and normal respiratory effort. Laboratory testing shows a urine protein/creatinine ratio of $0.35$, platelet count of $180{,}000/\\mu\\mathrm{L}$, serum creatinine of $0.7\\ \\mathrm{mg/dL}$, aspartate aminotransferase (AST) of $22\\ \\mathrm{U/L}$, and alanine aminotransferase (ALT) of $20\\ \\mathrm{U/L}$. There is no history of elevated blood pressure prior to pregnancy or before $20$ weeks’ gestation, and first-trimester records document normal blood pressures.\n\nUsing foundational diagnostic definitions for hypertensive disorders of pregnancy (e.g., new-onset hypertension defined by systolic blood pressure $\\geq 140\\ \\mathrm{mm\\ Hg}$ or diastolic blood pressure $\\geq 90\\ \\mathrm{mm\\ Hg}$ on two occasions at least $4$ hours apart after $20$ weeks’ gestation; proteinuria defined by $24$-hour protein $\\geq 300\\ \\mathrm{mg}$, protein/creatinine ratio $\\geq 0.3$, or dipstick $\\geq 2+$; and severe features including any of the following: systolic blood pressure $\\geq 160\\ \\mathrm{mm\\ Hg}$ or diastolic blood pressure $\\geq 110\\ \\mathrm{mm\\ Hg}$, platelet count $\\lt 100{,}000/\\mu\\mathrm{L}$, serum creatinine $>1.1\\ \\mathrm{mg/dL}$ or doubling of baseline, transaminases twice the upper limit of normal with persistent right upper quadrant pain, pulmonary edema, or new-onset cerebral or visual symptoms), which of the following best classifies her disorder and indicates whether severe features are present?\n\nA. Gestational hypertension without severe features\n\nB. Preeclampsia without severe features\n\nC. Preeclampsia with severe features\n\nD. Chronic hypertension\n\nE. White coat hypertension",
            "solution": "The problem statement will first be validated for scientific soundness, clarity, and completeness.\n\n### Step 1: Extract Givens\n\nThe verbatim data and definitions provided in the problem statement are as follows:\n\n**Patient Data:**\n- Gestational age: $28$ weeks\n- Blood pressure (BP) measurements: $146/92\\ \\mathrm{mm\\ Hg}$ and $150/94\\ \\mathrm{mm\\ Hg}$, separated by $4$ hours.\n- Reported symptoms: None (no headache, visual changes, right upper quadrant or epigastric pain, dyspnea, or decreased fetal movement).\n- Physical examination: No edema, normal respiratory effort.\n- Laboratory results:\n    - Urine protein/creatinine ratio (UPCr): $0.35$\n    - Platelet count: $180{,}000/\\mu\\mathrm{L}$\n    - Serum creatinine: $0.7\\ \\mathrm{mg/dL}$\n    - Aspartate aminotransferase (AST): $22\\ \\mathrm{U/L}$\n    - Alanine aminotransferase (ALT): $20\\ \\mathrm{U/L}$\n- Patient history: No history of elevated BP prior to pregnancy or before $20$ weeks’ gestation. Normal first-trimester BP records.\n\n**Diagnostic Definitions:**\n- **New-onset hypertension:** Systolic BP $\\geq 140\\ \\mathrm{mm\\ Hg}$ or diastolic BP $\\geq 90\\ \\mathrm{mm\\ Hg}$ on two occasions at least $4$ hours apart after $20$ weeks’ gestation.\n- **Proteinuria:** $24$-hour protein $\\geq 300\\ \\mathrm{mg}$, protein/creatinine ratio $\\geq 0.3$, or dipstick $\\geq 2+$.\n- **Severe features:** Any of the following:\n    - Systolic BP $\\geq 160\\ \\mathrm{mm\\ Hg}$ or diastolic BP $\\geq 110\\ \\mathrm{mm\\ Hg}$.\n    - Platelet count $< 100{,}000/\\mu\\mathrm{L}$.\n    - Serum creatinine $> 1.1\\ \\mathrm{mg/dL}$ or doubling of baseline.\n    - Transaminases twice the upper limit of normal with persistent right upper quadrant pain.\n    - Pulmonary edema.\n    - New-onset cerebral or visual symptoms.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem provides a clinical case and a set of explicit diagnostic criteria to be used for classification. These criteria are consistent with those published by major medical bodies, such as the American College of Obstetricians and Gynecologists (ACOG). The problem is scientifically grounded, objective, and self-contained, providing all necessary information to arrive at a logical conclusion. There are no contradictions, ambiguities, or factual inaccuracies. The problem requires a differential diagnosis based on a systematic application of formal definitions, which is a valid and well-posed task.\n\n### Step 3: Verdict and Action\n\nThe problem statement is valid. A definitive solution can be derived by applying the given definitions to the patient's data.\n\n### Derivation of Solution\n\nThe diagnostic process requires a systematic evaluation of the patient's clinical and laboratory data against the provided definitions.\n\n1.  **Assess for Hypertension:**\n    - The patient is at $28$ weeks of gestation, which is after the $20$-week threshold.\n    - The patient has two BP measurements: $146/92\\ \\mathrm{mm\\ Hg}$ and $150/94\\ \\mathrm{mm\\ Hg}$.\n    - For the first reading, the systolic BP ($146\\ \\mathrm{mm\\ Hg}$) is $\\geq 140\\ \\mathrm{mm\\ Hg}$, and the diastolic BP ($92\\ \\mathrm{mm\\ Hg}$) is $\\geq 90\\ \\mathrm{mm\\ Hg}$.\n    - For the second reading, the systolic BP ($150\\ \\mathrm{mm\\ Hg}$) is $\\geq 140\\ \\mathrm{mm\\ Hg}$, and the diastolic BP ($94\\ \\mathrm{mm\\ Hg}$) is $\\geq 90\\ \\mathrm{mm\\ Hg}$.\n    - The readings were obtained $4$ hours apart.\n    - There is no history of hypertension before $20$ weeks.\n    - Conclusion: The patient fulfills the definition of **new-onset hypertension** (or gestational hypertension if considered in isolation).\n\n2.  **Assess for Preeclampsia:**\n    - Preeclampsia is defined as new-onset hypertension with the presence of proteinuria or, in its absence, the new onset of any of the listed severe features.\n    - We must check for proteinuria. The definition for proteinuria includes a urine protein/creatinine ratio $\\geq 0.3$.\n    - The patient's UPCr is $0.35$.\n    - Since $0.35 \\geq 0.3$, the patient meets the criterion for **proteinuria**.\n    - Conclusion: The patient has new-onset hypertension and proteinuria. Therefore, the diagnosis is **preeclampsia**.\n\n3.  **Assess for Severe Features:**\n    - We must now determine if the preeclampsia is \"with\" or \"without\" severe features by checking each criterion.\n    - **Severe-range BP:** The highest recorded BP is $150/94\\ \\mathrm{mm\\ Hg}$. The systolic pressure ($150\\ \\mathrm{mm\\ Hg}$) is not $\\geq 160\\ \\mathrm{mm\\ Hg}$, and the diastolic pressure ($94\\ \\mathrm{mm\\ Hg}$) is not $\\geq 110\\ \\mathrm{mm\\ Hg}$. This criterion is **not met**.\n    - **Thrombocytopenia:** The platelet count is $180{,}000/\\mu\\mathrm{L}$. This is not $< 100{,}000/\\mu\\mathrm{L}$. This criterion is **not met**.\n    - **Renal insufficiency:** The serum creatinine is $0.7\\ \\mathrm{mg/dL}$. This is not $> 1.1\\ \\mathrm{mg/dL}$. As this is a normal value, doubling of baseline is biochemically implausible. This criterion is **not met**.\n    - **Impaired liver function:** The AST is $22\\ \\mathrm{U/L}$ and the ALT is $20\\ \\mathrm{U/L}$. These values are within normal limits and are not elevated, let alone twice the upper limit of normal. The patient also denies right upper quadrant pain. This criterion is **not met**.\n    - **Pulmonary edema:** The patient denies dyspnea and has normal respiratory effort on exam. This criterion is **not met**.\n    - **New-onset cerebral or visual symptoms:** The patient explicitly denies headache and visual changes. This criterion is **not met**.\n    - Conclusion: The patient does not meet any of the criteria for **severe features**.\n\n4.  **Final Diagnosis Synthesis:**\n    - The patient has preeclampsia (new-onset hypertension plus proteinuria).\n    - The patient does not have any severe features.\n    - The final diagnosis is **preeclampsia without severe features**.\n\n### Option-by-Option Analysis\n\n**A. Gestational hypertension without severe features**\nThis diagnosis applies to patients with new-onset hypertension after $20$ weeks' gestation but **without** proteinuria or any of the severe features. This patient has a UPCr of $0.35$, which meets the criterion for proteinuria. Therefore, this option is incorrect.\n**Verdict: Incorrect**\n\n**B. Preeclampsia without severe features**\nThis diagnosis applies to patients meeting the criteria for preeclampsia (new-onset hypertension with proteinuria or other end-organ dysfunction) who do not meet any criteria for severe features. As derived above, this patient has new-onset hypertension and proteinuria, but no severe features. This option accurately describes the patient’s condition.\n**Verdict: Correct**\n\n**C. Preeclampsia with severe features**\nThis diagnosis requires that the patient meet at least one of the criteria for severe features. As systematically analyzed above, the patient's blood pressure, laboratory values, and reported symptoms do not meet any of the thresholds for severe features.\n**Verdict: Incorrect**\n\n**D. Chronic hypertension**\nThis diagnosis is defined by hypertension that is present before pregnancy or diagnosed before $20$ weeks’ gestation. The problem statement explicitly notes that the patient had no history of elevated blood pressure and had normal blood pressures documented in the first trimester.\n**Verdict: Incorrect**\n\n**E. White coat hypertension**\nThis refers to elevated blood pressure readings only in a clinical setting, with normal readings at home. While the BPs were measured in a clinic, the diagnosis of preeclampsia is established by the combination of hypertension and proteinuria, a systemic pathological condition, not just an anxiety-related BP spike. The provided definitions for hypertensive disorders of pregnancy, when met, supersede a speculative diagnosis of white coat hypertension.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "The critical purpose of diagnosis is to inform management and mitigate risk, especially when a patient's condition evolves. This scenario challenges you to identify a severe feature of preeclampsia based on laboratory data, even in the absence of overt symptoms. Applying this finding will test your ability to make a time-sensitive, evidence-based decision regarding delivery, highlighting the direct link between vigilant monitoring, accurate classification, and improved maternal-fetal outcomes. ",
            "id": "4465857",
            "problem": "A $29$-year-old primigravid woman at $35$ weeks $2$ days with a history of gestational hypertension presents for routine follow-up. She has had home Blood Pressure (BP) readings in the $140$–$150$/$90$–$96$ mm Hg range over the past week. In clinic today, BP is $148/94$ mm Hg. She denies headache, visual changes, and Right Upper Quadrant (RUQ) or epigastric pain. Fetal movement is normal. Physical examination is unremarkable with no edema, clonus, or focal neurologic findings. Laboratory results are notable for platelet count $165\\times 10^3/\\mu\\text{L}$, serum creatinine $0.8$ mg/dL, urine protein-to-creatinine ratio $0.4$, aspartate aminotransferase (AST) $78$ U/L (laboratory upper limit of normal $35$ U/L), and alanine aminotransferase (ALT) $92$ U/L (laboratory upper limit of normal $40$ U/L). These transaminases were previously normal two weeks ago and have risen progressively.\n\nUsing foundational criteria for diagnosing preeclampsia and its severe features established by well-validated consensus guidelines (for example, those of the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM)), determine whether the current findings constitute a severe feature. Then, based on maternal-fetal risk principles, indicate the appropriate change in management at this gestational age.\n\nWhich one of the following is the best next step?\n\nA. This does not constitute a severe feature; continue outpatient expectant management and plan delivery at $37$ weeks without magnesium sulfate.\n\nB. This constitutes a severe feature (impaired liver function); admit for maternal-fetal monitoring, initiate magnesium sulfate for seizure prophylaxis, and proceed to delivery given gestational age $\\ge 34$ weeks after stabilization.\n\nC. This constitutes a severe feature only if accompanied by persistent RUQ pain; absent pain, maintain current management and plan elective delivery at $39$ weeks.\n\nD. This constitutes a severe feature; start antihypertensive therapy immediately and delay delivery until $37$ weeks without magnesium sulfate, as BP is not in the severe range.\n\nE. This does not constitute a severe feature; the likely diagnosis is intrahepatic cholestasis of pregnancy, so order serum bile acids and defer any change in management pending results.",
            "solution": "The validity of the problem statement is first assessed.\n\n**Step 1: Extract Givens**\n-   Patient: A $29$-year-old primigravid woman.\n-   Gestational Age (GA): $35$ weeks $2$ days.\n-   History: Gestational hypertension.\n-   Home Blood Pressure (BP): $140$–$150$/$90$–$96$ mm Hg range over the past week.\n-   Clinic BP: $148/94$ mm Hg.\n-   Symptoms: Denial of headache, visual changes, and Right Upper Quadrant (RUQ) or epigastric pain.\n-   Fetal Status: Normal fetal movement.\n-   Physical Examination: Unremarkable; no edema, clonus, or focal neurologic findings.\n-   Laboratory Data:\n    -   Platelet count: $165 \\times 10^3/\\mu\\text{L}$.\n    -   Serum creatinine: $0.8$ mg/dL.\n    -   Urine protein-to-creatinine ratio: $0.4$.\n    -   Aspartate aminotransferase (AST): $78$ U/L (laboratory upper limit of normal $35$ U/L).\n    -   Alanine aminotransferase (ALT): $92$ U/L (laboratory upper limit of normal $40$ U/L).\n-   Additional Context: Transaminases were previously normal two weeks ago and have shown progressive increase.\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientifically Grounded:** The problem describes a realistic clinical case within obstetrics, concerning hypertensive disorders of pregnancy. The data, terminology, and diagnostic framework are consistent with established medical science and clinical practice guidelines (e.g., ACOG). The scenario is biologically and medically plausible.\n-   **Well-Posed:** The problem provides sufficient, consistent data to arrive at a diagnosis and formulate a management plan based on standard-of-care guidelines. It asks for the \"best next step,\" which implies a single optimal course of action based on the provided information.\n-   **Objective:** The problem statement consists of objective clinical findings (BP measurements, lab results) and patient-reported symptoms (or lack thereof). It avoids subjective or ambiguous language.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. It is scientifically sound, well-posed, and objective. A solution will be derived based on a formal analysis of the clinical data against established diagnostic criteria.\n\n**Derivation of Solution**\n\nThe analysis proceeds in three stages:\n1.  Establish the diagnosis of preeclampsia.\n2.  Assess for the presence of severe features.\n3.  Determine the appropriate management based on the diagnosis, severity, and gestational age.\n\n**1. Diagnosis of Preeclampsia**\nAccording to consensus guidelines (e.g., ACOG), the diagnosis of preeclampsia is established by new-onset hypertension after $20$ weeks of gestation accompanied by either proteinuria or specific signs of end-organ dysfunction.\n-   **Hypertension:** The patient has a history of gestational hypertension. Multiple BP readings are in the hypertensive range ($\\ge 140$ mm Hg systolic or $\\ge 90$ mm Hg diastolic). Her clinic BP is $148/94$ mm Hg. This criterion is met.\n-   **Proteinuria:** This is defined as a urine protein-to-creatinine ratio of $\\ge 0.3$, a $24$-hour urine protein of $\\ge 300$ mg, or a dipstick reading of $\\ge 2+$. The patient's urine protein-to-creatinine ratio is $0.4$, which is greater than the threshold of $0.3$. This criterion is met.\n\nTherefore, the patient fulfills the diagnostic criteria for preeclampsia.\n\n**2. Assessment for Severe Features**\nPreeclampsia is further classified as \"with severe features\" if any of the following are present:\n-   **Severe hypertension:** Systolic BP $\\ge 160$ mm Hg or diastolic BP $\\ge 110$ mm Hg. The patient's BP of $148/94$ mm Hg does not meet this criterion.\n-   **Thrombocytopenia:** Platelet count $< 100 \\times 10^3/\\mu\\text{L}$. The patient's platelet count is $165 \\times 10^3/\\mu\\text{L}$, which is normal. This criterion is not met.\n-   **Impaired liver function:** This is defined as serum transaminase concentrations (AST or ALT) elevated to at least twice ($2\\times$) the upper limit of normal OR severe persistent RUQ or epigastric pain unresponsive to medication.\n    -   The patient's AST is $78$ U/L. The upper limit of normal (ULN) is $35$ U/L. $2 \\times 35$ U/L $= 70$ U/L. The patient's AST ($78$ U/L) is greater than twice the ULN.\n    -   The patient's ALT is $92$ U/L. The ULN is $40$ U/L. $2 \\times 40$ U/L $= 80$ U/L. The patient's ALT ($92$ U/L) is also greater than twice the ULN.\n    -   Thus, the criterion for impaired liver function is met based on the liver enzyme levels, irrespective of the absence of RUQ/epigastric pain.\n-   **Progressive renal insufficiency:** Serum creatinine $> 1.1$ mg/dL or a doubling of baseline creatinine. The patient's creatinine is $0.8$ mg/dL. This criterion is not met.\n-   **Pulmonary edema:** Not present on examination.\n-   **New-onset cerebral or visual disturbances:** The patient denies these symptoms.\n\nConclusion: The patient has preeclampsia with a severe feature, specifically impaired liver function.\n\n**3. Determination of Management**\nThe management of preeclampsia with severe features depends critically on the gestational age.\n-   The patient is at $35$ weeks $2$ days gestation.\n-   For preeclampsia with severe features diagnosed at or beyond $34$ weeks $0$ days of gestation, standard-of-care guidelines recommend delivery after maternal stabilization. Expectant management is not recommended due to high maternal and fetal risks.\n-   Maternal stabilization for preeclampsia with severe features includes seizure prophylaxis with intravenous magnesium sulfate. This is administered to prevent eclampsia, a life-threatening complication.\n-   Therefore, the correct course of action is to admit the patient to the hospital for maternal and fetal monitoring, initiate magnesium sulfate for seizure prophylaxis, and proceed with delivery.\n\n**Evaluation of Options**\n\n**A. This does not constitute a severe feature; continue outpatient expectant management and plan delivery at $37$ weeks without magnesium sulfate.**\nThis statement is incorrect. The patient's liver transaminase levels (AST $> 2\\times$ ULN and ALT $> 2\\times$ ULN) definitively constitute a severe feature. Consequently, expectant management until $37$ weeks is not appropriate. Delivery is indicated, and magnesium sulfate is required for seizure prophylaxis.\nVerdict: **Incorrect**.\n\n**B. This constitutes a severe feature (impaired liver function); admit for maternal-fetal monitoring, initiate magnesium sulfate for seizure prophylaxis, and proceed to delivery given gestational age $\\ge 34$ weeks after stabilization.**\nThis statement correctly identifies that the findings constitute a severe feature (impaired liver function). The proposed management plan—admission, maternal-fetal monitoring, magnesium sulfate for seizure prophylaxis, and proceeding to delivery—is fully consistent with established guidelines for managing preeclampsia with severe features at a gestational age of $35$ weeks $2$ days.\nVerdict: **Correct**.\n\n**C. This constitutes a severe feature only if accompanied by persistent RUQ pain; absent pain, maintain current management and plan elective delivery at $39$ weeks.**\nThis statement is incorrect. The diagnostic criteria for impaired liver function as a severe feature are disjunctive: elevated transaminases OR severe pain. The presence of transaminases more than twice the ULN is sufficient on its own. Since a severe feature is present, planning for delivery at $39$ weeks is inappropriate and dangerous.\nVerdict: **Incorrect**.\n\n**D. This constitutes a severe feature; start antihypertensive therapy immediately and delay delivery until $37$ weeks without magnesium sulfate, as BP is not in the severe range.**\nThis statement is incorrect on multiple grounds. While it correctly identifies the presence of a severe feature, the proposed management is flawed. First, delaying delivery until $37$ weeks is contraindicated for preeclampsia with severe features at this gestational age. Second, magnesium sulfate is indicated for seizure prophylaxis in all cases of preeclampsia with severe features, not just those with severe-range BPs. Third, immediate antihypertensive therapy is reserved for severe-range BPs ($\\ge 160/110$ mmHg), which this patient does not have.\nVerdict: **Incorrect**.\n\n**E. This does not constitute a severe feature; the likely diagnosis is intrahepatic cholestasis of pregnancy, so order serum bile acids and defer any change in management pending results.**\nThis statement is incorrect. The findings do constitute a severe feature of preeclampsia. While intrahepatic cholestasis of pregnancy (ICP) can cause elevated transaminases, the patient's clinical picture of hypertension and proteinuria makes preeclampsia the primary and most urgent diagnosis. Attributing the findings to ICP and delaying definitive management for preeclampsia would be a critical clinical error, placing both mother and fetus at significant risk.\nVerdict: **Incorrect**.",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}